케이엠제약

225430KOSDAQ기타 화학제품 제조업

55.3 / 100

Reference Date: 2026-06-10

Financial Score11.5 / 40

News Sentiment20.8 / 25

Momentum13.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Surged 315.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

KEM Pharmaceuticals specializes in oral care, beauty care, and daily necessities, offering a wide range of products such as children's and adult toothpaste, shampoo, body wash, and anti-wrinkle skincare. Its flagship brands, 'Pororo Friends' and 'Kkoma Bus Taeyo,' account for approximately 33.4% of sales, with active OEM/ODM business. The company aims to expand its domestic and international distribution channels and grow into a comprehensive daily necessities company by maintaining high-quality products.

Number of Employees

63people

Average Salary

42.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 16.504.0Point

PBR

0.42Industry Average 1.137.0Point

Half of industry avg (excellent)

ROE

-13.04Industry Average 4.550.0Point

Well below industry avg

Debt Ratio

22.04Industry Average 8.130.0Point

2.7x industry avg (risky)

Trend 2023~20250.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼4.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼74.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.0% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 83.3

Positive
케이엠제약, 美 파트너사와 현지 시장 진출 MOU
케이엠제약이 미국 파트너사와 MOU 체결로 현지 시장 진출 확대 기대, 긍정적 성장 전망.
Positive
케이엠제약, 美시장 공략 본격화…현지 파트너와 전략적 협력 추진
케이엠제약이 미국 현지 파트너와의 전략적 협력으로 미국 시장 진출을 가속화하여 긍정적인 성장 전망을 보임.
Positive
케이엠제약, '뽀로로 치약' 리뉴얼 출시
케이엠제약의 '뽀로로 치약' 리뉴얼 출시로 어린이 구강케어 시장에서의 경쟁력 강화 기대.

Detailed Momentum

52-week position6.0Point

52w upper range (67%)

Current 2,150Won52-week high 3,03552-week low 340

1-month return6.0Point

1m +315.86% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral주주총회소집공고2026-06-05
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-01
Neutral[기재정정]분기보고서 (2026.03)2026-05-29
Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-05-18